BlackRock Japan’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$110M Buy
522,627
+10,870
+2% +$2.25M 0.36% 59
2016
Q3
$118M Buy
511,757
+6,524
+1% +$1.59M 0.4% 51
2016
Q2
$117M Sell
505,233
-21,916
-4% -$5.05M 0.42% 49
2016
Q1
$141M Sell
527,149
-38,996
-7% -$11.2M 0.53% 41
2015
Q4
$177M Sell
566,145
-27,283
-5% -$8.12M 0.66% 31
2015
Q3
$161M Buy
593,428
+57,550
+11% +$17.7M 0.65% 31
2015
Q2
$163M Buy
535,878
+1,444
+0.3% +$431K 0.63% 34
2015
Q1
$159M Buy
534,434
+112,230
+27% +$32M 0.64% 32
2014
Q4
$109M Buy
422,204
+20,160
+5% +$5.04M 0.42% 51
2014
Q3
$97M Buy
402,044
+124,572
+45% +$27.9M 0.42% 49
2014
Q2
$61.9M Sell
277,472
-26,579
-9% -$5.5M 0.28% 86
2014
Q1
$62.6M Buy
304,051
+97,980
+48% +$19.4M 0.28% 85
2013
Q4
$34.6M Buy
206,071
+50,594
+33% +$7.91M 0.15% 154
2013
Q3
$22.4M Buy
155,477
+5,085
+3% +$677K 0.11% 224
2013
Q2
$19M Buy
+150,392
New +$17M 0.09% 261

Other funds holding AGN

BlackRock Japan's AGN Position: Q4 2016 in Review

BlackRock Japan increased its Allergan plc (AGN) stake by 2.1% in Q4 2016, buying an estimated $2.25M and bringing the position to 522,627 shares worth $110M. The position accounts for 0.36% of the portfolio, ranked #59.

BlackRock Japan first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $177M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • BlackRock Japan held 522,627 shares of Allergan plc worth $110M as of Q4 2016.
  • BlackRock Japan bought 10,870 Allergan plc shares in Q4 2016, an estimated $2.25M.
  • Allergan plc made up 0.36% of BlackRock Japan's portfolio in Q4 2016, its #59 holding.
  • BlackRock Japan first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's Allergan plc position peaked at $177M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.